You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 285 No. 5, February 7, 2001 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Research Opportunities for Specific Diseases and Disorders
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (39)
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Statistics and Research Methods
 •Alert me on articles by topic

Prospects for Cardiovascular Research

Robert J. Lefkowitz, MD; James T. Willerson, MD

JAMA. 2001;285:581-587.

Cardiovascular disease is the greatest threat to human life and health. The past decade has seen remarkable progress in clinical and basic cardiovascular research, and many areas of opportunity are promising. The pace of current progress in clinical and basic research is such that remarkable improvement in the quality and length of life for those at risk for cardiovascular disease is likely.


Author Affiliations: Howard Hughes Medical Institute, Chevy Chase, Md, and Departments of Medicine and Biochemistry, Duke University, Durham, NC (Dr Lefkowitz); Texas Heart Institute, Houston, and Department of Internal Medicine, University of Texas Medical School, Houston (Dr Willerson).


RELATED LETTER

Incidence of Congenital Heart Disease
Norman J. Sissman, James T. Willerson, and Robert J. Lefkowitz
JAMA. 2001;285(20):2579-2580.
EXTRACT | FULL TEXT  

RELATED ARTICLE

February 7, 2001
JAMA. 2001;285(5):665-666.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Fate of Incidental, Asymptomatic Lesions Discovered During Percutaneous Coronary Intervention
Caymaz and Yuksel
ANGIOLOGY 2008;59:193-197.
ABSTRACT  

Narrative Review: Assessment of C-Reactive Protein in Risk Prediction for Cardiovascular Disease
Lloyd-Jones et al.
ANN INTERN MED 2006;145:35-42.
ABSTRACT | FULL TEXT  

Oxidative Stress and Vascular Disease
Madamanchi et al.
Arterioscler. Thromb. Vasc. Bio. 2005;25:29-38.
ABSTRACT | FULL TEXT  

Mathematical estimation of the potential effect of vascular remodelling/dilatation on B-mode ultrasound intima-medial thickness
Eigenbrodt et al.
QJM 2004;97:729-737.
ABSTRACT | FULL TEXT  

E-Selectin Blockade Decreases Adventitial Inflammation and Attenuates Intimal Hyperplasia in Rat Carotid Arteries After Balloon Injury
Gotoh et al.
Arterioscler. Thromb. Vasc. Bio. 2004;24:2063-2068.
ABSTRACT | FULL TEXT  

Inflammation as a Cardiovascular Risk Factor
Willerson and Ridker
Circulation 2004;109:II-2-II-10.
ABSTRACT | FULL TEXT  

Physiology and Pathophysiology of Vascular Signaling Controlled by Cyclic Guanosine 3',5'-Cyclic Monophosphate-Dependent Protein Kinase
Munzel et al.
Circulation 2003;108:2172-2183.
FULL TEXT  

From Vulnerable Plaque to Vulnerable Patient: A Call for New Definitions and Risk Assessment Strategies: Part II
Naghavi et al.
Circulation 2003;108:1772-1778.
ABSTRACT | FULL TEXT  

Re-assessing the contribution of serum total cholesterol, blood pressure and cigarette smoking to the aetiology of coronary heart disease: impact of regression dilution bias
Emberson et al.
Eur Heart J 2003;24:1719-1726.
ABSTRACT | FULL TEXT  

Major Risk Factors as Antecedents of Fatal and Nonfatal Coronary Heart Disease Events
Greenland et al.
JAMA 2003;290:891-897.
ABSTRACT | FULL TEXT  

Prevalence of Conventional Risk Factors in Patients With Coronary Heart Disease
Khot et al.
JAMA 2003;290:898-904.
ABSTRACT | FULL TEXT  

Low-Density Lipoprotein in Hypercholesterolemic Human Plasma Induces Vascular Endothelial Cell Apoptosis by Inhibiting Fibroblast Growth Factor 2 Transcription
Chen et al.
Circulation 2003;107:2102-2108.
ABSTRACT | FULL TEXT  

Time2Take on risk -- making the link between insulin resistance and cardiovascular risk: Report of a GSK symposium from Diabetes UK, Glasgow, March 19th 2003
British Journal of Diabetes & Vascular Disease 2003;3:S1-S8.
 

Cardiovascular Reactivity: Status Quo and a Research Agenda for the New Millennium
Linden et al.
Psychosom. Med. 2003;65:5-8.
ABSTRACT | FULL TEXT  

The search for new risk factors for coronary heart disease: occupational therapy for epidemiologists?
Beaglehole and Magnus
Int J Epidemiol 2002;31:1117-1122.
ABSTRACT | FULL TEXT  

Carotid Intima-Media Thickness Is Associated With Allelic Variants of Stromelysin-1, Interleukin-6, and Hepatic Lipase Genes: The Northern Manhattan Prospective Cohort Study
Rundek et al.
Stroke 2002;33:1420-1423.
ABSTRACT | FULL TEXT  

The Real Contribution of the Major Risk Factors to the Coronary Epidemics: Time to End the "Only-50%" Myth
Magnus and Beaglehole
Arch Intern Med 2001;161:2657-2660.
FULL TEXT  

Incidence of Congenital Heart Disease
Sissman et al.
JAMA 2001;285:2579-2580.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.